Some of the fattest annual profit margins come from drugmakers whose products are meant to make people healthier. Today’s Screen of the Day is Healthy Profit Margin and includes four highly rated drug stocks. Don’t miss out on Jazz Pharmaceuticals (JAZZ) and its annual profit margin of 54.4%. Its narcolepsy treatment, Xyrem, has rocketed to success and contributed to 65% of the drugmaker’s 2013 revenue. The company has an IBD Composite Rating of
Tech stocks, and especially Internet leaders such as LinkedIn (LNKD), often have big expectations on their shoulders, so investors should be on alert when those expectations are nudged even higher. Today’s IBD Screen of the Day is Leaders with Rising Estimates, which features top-rated stocks with the biggest jump in earnings estimate revisions. LinkedIn is a site where professionals can connect with others seeking career information. The company,
Stability is a critical determination in picking stock-watch candidates when the market is in correction. Today’s Screen Of The Day is Big Cap Leaders, companies with top-notch fundamentals and a market capitalization of at least $15 billion. The list includes well-known names and some lesser-known ones that might be undiscovered gems. Gilead Sciences (GILD), No. 1 on the Big Cap Screen list, is known for